LunagisthubNigeria Set to Receive Game-Changing HIV Prevention Drug in March
Nigeria is poised to revolutionize its HIV prevention efforts with the arrival of Lenacapavir, a groundbreaking injectable drug that has shown 100% effectiveness in preventing HIV infection in clinical trials. The National Agency for the Control of AIDS (NACA) has secured regulatory approval from the National Agency for Food and Drug Administration and Control (NAFDAC) and is advancing preparations for its introduction as Pre-Exposure Prophylaxis (PrEP)
– Lenacapavir is administered twice a year, making it a more convenient alternative to daily oral prevention drugs.
– The drug will be available in Nigeria and 119 other low- and middle-income countries at an affordable price of $40 per person annually.
– NACA has completed landscape and readiness assessments across ten states, including Akwa Ibom, Anambra, and Lagos.
– Nigeria has approximately 1.9 million people living with HIV, with a national prevalence of 1.3% among adults aged 15-49 years.
How do you think the introduction of Lenacapavir will impact Nigeria’s HIV prevention efforts? Will this game-changing drug help accelerate progress toward epidemic control?
Lunagisthub
